Greenwood Capital Associates LLC Emergent Bio Solutions Inc. Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$27.42 - $43.63 $440,557 - $701,003	-16,067 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$36.48 - $52.22 $20,209 - $28,929	554 Added 3.57%	16,067 $660,000
Q4 2021 Feb 03, 2022	BUY	$33.11 - $55.01 $3,410 - $5,666	103 Added 0.67%	15,513 $674,000
Q3 2021 Oct 27, 2021	SELL	$50.07 - $66.05 $19,627 - $25,891	-392 Reduced 2.48%	15,410 $772,000
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $3,962 - $5,632	70 Added 0.44%	15,802 $995,000
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $94,163 - $136,707	1,092 Added 7.46%	15,732 $1.46 Million
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $232,680 - $327,610	2,939 Added 25.12%	14,640 $1.31 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $3,522 - $5,802	43 Added 0.37%	11,701 $1.21 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $114,255 - $188,260	2,103 Added 22.01%	11,658 $922,000
Q1 2020 May 12, 2020	SELL	$49.34 - $68.76 $29,752 - $41,462	-603 Reduced 5.94%	9,555 $553,000
Q4 2019 Feb 12, 2020	BUY	$51.21 - $59.06 $89,617 - $103,355	1,750 Added 20.81%	10,158 $548,000
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $27,242 - $38,381	671 Added 8.67%	8,408 $440,000
Q2 2019 Aug 13, 2019	BUY	$39.92 - $53.86 $11,616 - $15,673	291 Added 3.91%	7,737 $374,000
Q1 2019 May 03, 2019	BUY	$48.23 - $66.16 $54,258 - $74,430	1,125 Added 17.8%	7,446 $376,000
Q4 2018 Feb 11, 2019	BUY	$55.63 - $73.24 $41,277 - $54,344	742 Added 13.3%	6,321 $375,000
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $1,353 - $1,729	26 Added 0.47%	5,579 $367,000
Q2 2018 Aug 07, 2018	BUY	$48.33 - $55.64 $45,430 - $52,301	940 Added 20.38%	5,553 $280,000
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $10,932 - $13,379	-246 Reduced 5.06%	4,613 $243,000
Q4 2017 Feb 02, 2018	BUY	$37.77 - $47.75 $183,524 - $232,017	4,859	4,859 $226,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$33.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.9 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.9 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.6 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.8 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account